Latest stories on AVBP
ArriVent BioPharma GAAP EPS of -$1.05 misses by $0.06
Seeking Alpha34 · bearishearnings
ArriVent inks China partnership for ARR-002 development
TipRanks63 · neutralproduct/pr
ArriVent BioPharma, Inc. (AVBP) files 8-K
SEC 8-K50 · neutralgeneral
ArriVent BioPharma Reports Second Quarter 2026 Financial Results
StockTitan50 · neutralearnings
ArriVent BioPharma Stockholders Back Board and Auditor Slate
TipRanks50 · neutralgeneral
ArriVent BioPharma, Inc. (AVBP) files 8-K
SEC 8-K50 · neutralgeneral
The Evolving EGFR NSCLC Market: 8 Emerging Late-stage Therapies to Watch | DelveInsight
PR Newswire58 · neutralgeneral
ArriVent BioPharma: Stronger Balance Sheet And Pipeline Upside Reinforce Our Bull Case
Seeking Alpha73 · bullishanalyst